PATENT CLAIM ANALYSIS

Application Number: 16109198
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2018-12
Patent Classification: ["424", "422000"]

Abstract:
Disclosed are biocompatible, biodegradable, implantable devices for the controlled release of bioactive molecules. In particular embodiments, nanotechnology-based tunable implants are disclosed for 1) localized delivery of analgesics to treat postoperative pain; 2) sustained delivery of growth factors to promote vascularization; and 3) directing tissue regeneration, including the self-direction of autologous stem cells for organ remodeling.

Claim (Index 14):
The biocompatible, implantable, multilayer delivery system of  claim 1 , further comprising an additional non-porous layer.

Metadata:
- Claim Count in Document: 42.0
- Percentile: 96.0
- Lexical Diversity: 1.32
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14967165', '13708888', '14266729', '11560352', '15270324']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6900705380962168
- 35 USC 102 Novelty (BERT): 0.4947451668705021
- Combined Prediction Score: 0.6705380009736452
- Mean Citation Score: 163.054886
- Max Citation Score: 170.39989
- Similarity Product: 103.39318219504597

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test